摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R,4S,5S)-4-[(tert-butyldimethylsilanyl)oxy]-3,5-dimethyltetrahydropyran-2-one | 444105-66-2

中文名称
——
中文别名
——
英文名称
(3R,4S,5S)-4-[(tert-butyldimethylsilanyl)oxy]-3,5-dimethyltetrahydropyran-2-one
英文别名
(3R,4S,5S)-4-(tert-butyldimethylsilanyloxy)-3,5-dimethyltetrahydropyran-2-one;(3R,4S,5S)-4-tert-butyl-dimethyl-silanyloxy-3,5-dimethyl-tetrahydro-pyran-2-one;(3R,4S,5S)-4-[tert-butyl(dimethyl)silyl]oxy-3,5-dimethyloxan-2-one
(3R,4S,5S)-4-[(tert-butyldimethylsilanyl)oxy]-3,5-dimethyltetrahydropyran-2-one化学式
CAS
444105-66-2
化学式
C13H26O3Si
mdl
——
分子量
258.433
InChiKey
GPFONLRHFZWMIM-AXFHLTTASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    53-54 °C
  • 沸点:
    308.5±35.0 °C(Predicted)
  • 密度:
    0.95±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.21
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.92
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] ANALOGS OF DISCODERMOLIDE AND DICTYOSTATIN-1, INTERMEDIATES THEREFOR AND METHODS OF SYNTHESIS THEREOF<br/>[FR] ANALOGUES DE DISCODERMOLIDE ET DE DICTYOSTATINE-1, INTERMEDIAIRES CORRESPONDANTS, ET PROCEDES DE SYNTHESE CORRESPONDANTS
    申请人:UNIV PITTSBURGH
    公开号:WO2004022552A1
    公开(公告)日:2004-03-18
    A compound of the following structure: wherein R1 is H, an alkyl group, an aryl group, an alkenyl group, an alkynyl group, or a halogen atom; R2 is H, an alkyl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; Ra, Rb and Rc are independently an alkyl group or an aryl group; Rd is an alkyl group, an aryl group, an alkoxylalkyl group, -RiSiRaRbRc or a benzyl group, wherein Ri is an alkylene group; Re is an alkyl group, an allyl group, a benzyl group, an aryl group, an alkoxy group, or -NRgRh, wherein Rg and Rh are independently H, an alkyl group or an aryl group; R3 is (CH2)n where n is and integer in the range of 0 to 5, -CH2CH(CH3)-, -CH=CH-, -CH=C(CH3)-, or -C=-C-; R4 is (CH2)p where p is an integer in the range of 4 to 12, -(CHRkl)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5C(Rsl )=C(Rs2)C(Rs3)=C(Rs4)-, -(CHRk1 )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rs I)CH(Rs2)C(Rs3)=C(Rs4)-, -(CHRk1)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRks)y5C(Rsl)=C(Rs2)CH(Rs3)CH(Rs4)-, -(CHRkI )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rsl)CH(Rs2)CH(Rs3)CH(R s4)-, wherein y1 and y2 are 1 and y3, y4 and y5 are independently 0 or 1, Rk1, Rk2, Rk3, Rk4 and Rk5 are independently H, CH3, or OR2a, and Rs1, Rs2, Rs3, and Rs4 are independently H or CH3, wherein R2a is H, an alkyl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; and R5 is H or OR2b, wherein R2b is H, an alkyl group, an aryl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; provided that the compound is not dictyostatin 1.
    以下是该结构的化合物:其中R1为H、烷基基团、芳基、烯基基团、炔基基团或卤素原子;R2为H、烷基基团、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe;Ra、Rb和Rc独立地为烷基基团或芳基;Rd为烷基基团、芳基、烷氧基烷基团、-RiSiRaRbRc或苄基,其中Ri为烷基烷基团;Re为烷基基团、烯丙基基团、苄基、芳基、烷氧基或-NRgRh,其中Rg和Rh独立地为H、烷基基团或芳基;R3为(CH2)n,其中n为0到5范围内的整数,-CH2CH(CH3)-、-CH=CH-、-CH=C(CH3)-或-C=-C-;R4为(CH2)p,其中p为4到12范围内的整数,-(CHRkl)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5C(Rsl )=C(Rs2)C(Rs3)=C(Rs4)-、-(CHRk1 )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rs I)CH(Rs2)C(Rs3)=C(Rs4)-、-(CHRk1)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRks)y5C(Rsl)=C(Rs2)CH(Rs3)CH(Rs4)-、-(CHRkI )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rsl)CH(Rs2)CH(Rs3)CH(R s4)-,其中y1和y2为1,y3、y4和y5独立地为0或1,Rk1、Rk2、Rk3、Rk4和Rk5独立地为H、CH3或OR2a,Rs1、Rs2、Rs3和Rs4独立地为H或CH3,其中R2a为H、烷基基团、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe;R5为H或OR2b,其中R2b为H、烷基基团、芳基、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe;前提是该化合物不是dictyostatin 1。
  • Evolution of a Gram-Scale Synthesis of (+)-Discodermolide
    作者:Amos B. Smith、Thomas J. Beauchamp、Matthew J. LaMarche、Michael D. Kaufman、Yuping Qiu、Hirokazu Arimoto、David R. Jones、Kaoru Kobayashi
    DOI:10.1021/ja0015287
    日期:2000.9.1
    stereocontrolled total synthesis of the potent antimitotic agent (+)-discodermolide (1) has been achieved on gram scale. Key elements of the successful strategy include (1) elaboration of three advanced fragments from a common precursor (CP) which embodies the repeating stereochemical triad of the discodermolide backbone, (2) σ-bond installation of the Z trisubstituted olefin, exploiting a modified Negishi cross-coupling
    有效的、高度收敛的、立体控制的有效抗有丝分裂剂 (+)-discodermolide (1) 的全合成已在克级实现。成功策略的关键要素包括 (1) 从共同前体 (CP) 精心制作三个高级片段,该片段体现了 discodermolide 主链的重复立体化学三元组,(2) Z 三取代烯烃的 σ 键安装,利用改进的 Negishi交叉偶联反应,(3) 利用高压合成后期鏻盐,以及 (4) Z 双取代烯烃和末端 (Z)-二烯的 Wittig 安装。
  • High 1,5-Anti Stereoinduction in Boron-Mediated Aldol Reactions of Methyl Ketones
    作者:Luiz C. Dias、Rosana Z. Baú、Márcio A. de Sousa、J. Zukerman-Schpector
    DOI:10.1021/ol026968c
    日期:2002.11.1
    [reaction: see text] We report herein a very efficient and synthetically useful 1,4-anti-1,5-anti boron-mediated aldol reaction of a chiral alpha-methyl-beta-alkoxy methyl ketone with achiral aldehydes.
    [反应:见正文]我们在此报告了一种非常有效且合成上有用的1,4-抗-1,5-抗硼介导的手性α-甲基-β-烷氧基甲基酮与非手性醛的羟醛反应。
  • [EN] SYNTHESIS OF DISCODERMOLIDE<br/>[FR] SYNTHESE DU DISCODERMOLIDE
    申请人:NOVARTIS AG
    公开号:WO2004009574A1
    公开(公告)日:2004-01-29
    The invention relates to a process for preparing discodermolide, for preparing intermediates for the manufacture of discodermolide and discodermolide analogues and to the intermediates obtained during the process. Wherein the process proceeds via a tetraene of formula (IV).
    该发明涉及一种制备discodermolide的过程,用于制备制造discodermolide和discodermolide类似物的中间体,以及在过程中获得的中间体。其中,该过程通过式(IV)的四烯体进行。
  • Studies on the total synthesis of sanglifehrin A: stereoselective synthesis of the C(29)–C(39) fragment
    作者:Luiz C. Dias、Airton G. Salles
    DOI:10.1016/j.tetlet.2006.01.105
    日期:2006.3
    A highly stereoselective synthesis of the C(29)–C(39) fragment of the potent immunosuppressant sanglifehrin A has been accomplished by a sequence involving 16 steps (18% overall yield) from N-propionyloxazolidinone 9. Key steps are a diastereoselective hydroboration, and a diastereoselective epoxidation of an allylic alcohol followed by a 1,5-anti boron-mediated aldol reaction of methyl ketone 4 with
    在C(29)-C(39)的有效的免疫抑制剂萨菲菌素A的片段的高度立体选择性合成已经由从包括16步(18%总收率)的序列来完成Ñ -propionyloxazolidinone 9。关键步骤是非对映选择性的硼氢化反应,以及烯丙醇的非对映选择性环氧化,然后是甲基酮4与手性醛5的1,5-抗硼介导的羟醛缩合反应。
查看更多